ZURICH (Reuters) - A Novartis lung drug met its main goals in three late-stage studies in patients with chronic obstructive pulmonary disease (COPD), often known as smokers' cough, the Swiss drugmaker said on Monday, giving its respiratory pipeline a boost.
sfo off airport parking boston car rental deals car hire uk airports
No comments:
Post a Comment